Parrish Capital’s Eli Lilly LLY Stock Holding History

Parrish Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-171	Closed	-$205K	–	87
2026 Q2	$205K	Buy	+171	New	+$175K	0.2%	83

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Parrish Capital's LLY Position: Q3 2026 in Review

Parrish Capital sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 171 shares — an estimated $205K sold.

Parrish Capital first reported a position in LLY in Q2 2026 and held it in 1 quarter. The position peaked at $205K in Q2 2026. 2,115 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Parrish Capital reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
Parrish Capital sold 171 Eli Lilly shares in Q3 2026, an estimated $205K.
Parrish Capital first reported a position in Eli Lilly in Q2 2026 and held it in 1 quarter.
Parrish Capital's Eli Lilly position peaked at $205K in Q2 2026.
2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Parrish Capital's 13F filing for Q3 2026, filed 1 Oct 2026.